YOU ARE HERE: LAT HomeCollectionsGenetic Engineering

Genetic Engineering

November 28, 2000 | Bloomberg News
Monsanto Co. said it will delay the launch of its rootworm-killing genetically engineered corn for a year to ensure that it gets full U.S. and Japanese government approval. St. Louis-based Monsanto is trying to avoid the problems competitor Aventis faces with its StarLink corn, which is at the center of a 300-product food recall in the U.S.
September 18, 2010 | By Andrew Zajac, Tribune Washington Bureau
In a step that may move genetically engineered meat and fish closer to the American dinner table, an FDA advisory committee will vote Monday on whether to approve preliminary findings that a modified salmon is as safe as an ordinary salmon. The vote is not binding on the FDA, but approval would lend powerful support for a final decision by the agency charged with protecting the nation's food and drug supplies. The fish, a North Atlantic salmon developed by AquaBounty Technologies Inc. would be the country's first genetically engineered food animal.
September 28, 1987 | Compiled from Staff and Wire Reports and
Roughly four in five Americans can neither define genetic engineering nor grasp enough about the science to understand the moral and ethical issues involved. Despite their admitted lack of knowledge, the public is generally optimistic about the potential benefits of genetic engineering. These and other findings regarding genetic engineering were revealed in the report of a study conducted by Research & Forecasts Inc. for Novo Industri A/S.
February 15, 2001
Genetic engineering may not be any more effective than conventional breeding at increasing the growth of farmed trout, according to Canadian researchers. Molecular biologist Robert Devlin and his colleagues at Fisheries and Oceans Canada inserted the gene for a growth hormone into a slow-growing strain of rainbow trout and found that the engineered fish grew much more rapidly.
June 9, 2001
In "The Politics of Cloning" (Opinion, June 3), Eric Cohen writes that "reproductive-rights activists . . . see cloning as a personal choice that the government should not meddle with." Though human cloning and the genetic redesign of future generations have in the past been entangled with the politics of abortion, this statement is now simply inaccurate. Many advocates of reproductive choice firmly oppose human cloning and inheritable genetic modifications. It is clear to us and to most people that a woman's right to terminate an unwanted pregnancy is a very different matter than the desire to control the genetic makeup of a future child.
September 3, 1998 | From Associated Press
Heightening environmentalists' fears about the dangers of genetic engineering, a weed that was altered by scientists to resist an herbicide also developed far greater ability to pollinate other plants and pass its traits on. The findings raise the possibility of the emergence of "superweeds" impervious to weedkillers.
February 27, 1987 | THOMAS H. MAUGH II, Times Science Writer
Scientists at Caltech, using genetic engineering techniques, have cured mice of an inherited neurological disease that causes them to shiver uncontrollably and die an early death. The disease, called shiverer mutation, involves a deficiency of myelin basic protein, which accounts for about 30% of the insulating material that sheathes nerves in both humans and mice, just as plastic insulators enclose copper wires in electrical cords.
September 21, 1989 | THOMAS H. MAUGH II and KEVIN DAVIS, Times Staff Writers
Organisms produced by genetic engineering techniques are fundamentally no different from those produced by conventional cross-breeding and are "not inherently dangerous," according to a report issued Wednesday by a special committee of the National Academy of Sciences. For tests of some microorganisms that have a potential to threaten the environment, the committee recommended introduction of a "suicide gene" that would cause the mutated bacteria or virus to self-destruct after the test.
May 20, 1988 | THOMAS H. MAUGH II, Times Science Writer
For the first time, researchers have been able to use genetic engineering techniques to produce key parts of disease-fighting antibodies in bacterial cells, a Santa Monica-based biotechnology company said in a report published today. Biologists at International Genetic Engineering Inc. (Ingene) used the technique to produce an antibody fragment that binds specifically to human colon cancer cells.
Los Angeles Times Articles